Serkies Krystyna, Tarnawska Zofia, Blukis Andrzej, Badzio Andrzej, Jaskiewicz Janusz, Jassem Jacek
Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.
Department of Plastic Surgery, Medical University of Gdansk, Poland.
J Contemp Brachytherapy. 2009 Mar;1(1):33-37. Epub 2009 Mar 23.
The aim of this work is to compare selected parameters of implants and natural dose volume histograms for two techniques of interstitial pulsed dose rate brachytherapy (PDR BT) as a boost to the tumour bed in breast-conserving therapy (BCT).
Data of TNM breast cancer patients who underwent BCT with BT boost between 05.2002 and 12.2008 were analysed. Ninety two patients were implanted with rigid tubes after breast irradiation (group A) and 96 had a peri-operative BT with an intra-operative flexible tube placement and subsequent whole breast radiotherapy (group B). In both groups PDR BT of 15 Gy (1 Gy/pulse/h) was administered based on Paris system rules, and volume optimization using BT planning system PLATO.
Three-plane implant was used in 62% and 8% of patients in group A and B, respectively, and two-plane implant in 38% of group A and in 84% of group B, with a median of 11 and 9 tubes respectively. The average volume for the prescribed dose (V) was 42.0 ± 25.4 cc (group A) and 34.1 ± 19.7 cc (group B), respectively (p = 0.017). The individual V and V were similar. Quality index (QI) was not impacted by the technique of BT (mean QI was 1.80 ± 0.10 and 1.75 ± 0.46 for the groups A and B, respectively). Uniformity index (UI) in respective groups was 1.60 ± 0.10 and 1.52 ± 0.21 (p = 0.001).
Implant volume encompassed by prescribed dose was significantly lower with intra-operative plastic tubes placement. In respect to the QI, these two BT techniques were comparable. The target volume coverage by the dose distribution as defined by UI was better for rigid tubes.
本研究旨在比较两种间质脉冲剂量率近距离放射治疗(PDR BT)技术用于保乳治疗(BCT)中瘤床加量时,植入物与天然剂量体积直方图的选定参数。
分析2002年5月至2008年12月期间接受BCT联合BT加量的TNM乳腺癌患者的数据。92例患者在乳腺照射后植入刚性导管(A组),96例患者在手术期间进行BT,术中放置柔性导管,随后进行全乳放疗(B组)。两组均根据巴黎系统规则给予15 Gy(1 Gy/脉冲/小时)的PDR BT,并使用BT计划系统PLATO进行体积优化。
A组和B组分别有62%和8%的患者使用了三平面植入,A组38%和B组84%的患者使用了双平面植入,A组和B组的导管中位数分别为11根和9根。规定剂量的平均体积(V)分别为42.0±25.4 cc(A组)和34.1±19.7 cc(B组)(p = 0.017)。个体V和V相似。质量指数(QI)不受BT技术的影响(A组和B组的平均QI分别为1.80±0.10和1.75±0.46)。各组的均匀性指数(UI)分别为1.60±0.10和1.52±0.21(p = 0.001)。
术中放置塑料导管时,规定剂量所涵盖的植入体积显著更低。就QI而言,这两种BT技术具有可比性。刚性导管在UI定义的剂量分布下对靶体积的覆盖更好。